Integra LifeSciences Holdings Corporation (FRA:IL3)
Germany · Delayed Price · Currency is EUR 9.10
+0.10 (1.11%)
At close: Jan 30, 2026
FRA:IL3 Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -495.34 | -6.94 | 67.74 | 180.55 | 169.08 | 133.89 |
Depreciation & Amortization | 158.09 | 140.89 | 123.51 | 118.3 | 119.84 | 116.03 |
Other Amortization | 5.99 | 5.59 | 6.16 | 6.85 | 7.03 | 27.49 |
Loss (Gain) From Sale of Assets | 0.65 | 1.5 | 0.78 | -7.46 | -39.56 | 7.86 |
Asset Writedown & Restructuring Costs | 504.3 | 12.21 | - | - | 2.75 | 0.52 |
Stock-Based Compensation | 19.9 | 24.38 | 20.14 | 27.73 | 36.21 | 19.59 |
Other Operating Activities | -73.91 | -17.24 | 3.19 | -22.07 | -1.08 | -60.23 |
Change in Accounts Receivable | -15.5 | 7.4 | 4.59 | -33.91 | 7.27 | 52.11 |
Change in Inventory | -43.99 | -28.15 | -59.77 | -29.12 | 5.37 | -48.35 |
Change in Accounts Payable | -1.66 | -2.67 | -20.23 | 17.34 | 32.87 | -57.51 |
Change in Unearned Revenue | 4.43 | 3.54 | 0.13 | 4.27 | 0.03 | -0.04 |
Change in Other Net Operating Assets | 26.33 | -11.12 | -6.29 | 1.99 | -27.38 | 12.48 |
Operating Cash Flow | 89.31 | 129.38 | 139.96 | 264.47 | 312.43 | 203.83 |
Operating Cash Flow Growth | -35.00% | -7.56% | -47.08% | -15.35% | 53.28% | -11.93% |
Capital Expenditures | -93.82 | -104.42 | -66.87 | -42.34 | -48.02 | -38.89 |
Sale of Property, Plant & Equipment | - | - | - | 11.15 | 0 | 3.66 |
Cash Acquisitions | 4.18 | -277.81 | - | -51.51 | -303.91 | - |
Divestitures | - | - | - | 23.96 | 190.47 | - |
Sale (Purchase) of Intangibles | -9.95 | -9.95 | - | -4.74 | -0.06 | -25 |
Investment in Securities | 26.75 | 5.5 | -32.69 | - | - | - |
Other Investing Activities | -4.56 | -4.13 | 5.38 | 4.91 | 0.08 | -7.84 |
Investing Cash Flow | -77.41 | -390.81 | -94.18 | -58.58 | -161.44 | -68.07 |
Long-Term Debt Issued | - | 486.5 | 165.1 | 40.75 | 25.5 | 746.5 |
Long-Term Debt Repaid | - | -187.13 | -110.6 | -148.55 | -125.5 | -441 |
Net Debt Issued (Repaid) | 21.66 | 299.37 | 54.5 | -107.8 | -100 | 305.5 |
Issuance of Common Stock | 0.96 | 6.4 | 4.32 | 5.47 | 6.82 | 5.23 |
Repurchase of Common Stock | -5.39 | -55.98 | -280.86 | -149.62 | -4.8 | -105.08 |
Other Financing Activities | -20.38 | -11.92 | -7.88 | - | -0.25 | -84.03 |
Financing Cash Flow | -3.16 | 237.86 | -229.93 | -251.95 | -98.23 | 121.63 |
Foreign Exchange Rate Adjustments | 8.28 | -6.46 | 3.89 | -10.72 | -9.48 | 13.87 |
Net Cash Flow | 17.03 | -30.03 | -180.26 | -56.79 | 43.28 | 271.26 |
Free Cash Flow | -4.51 | 24.96 | 73.09 | 222.13 | 264.41 | 164.94 |
Free Cash Flow Growth | - | -65.84% | -67.09% | -15.99% | 60.30% | 1.88% |
Free Cash Flow Margin | -0.27% | 1.55% | 4.74% | 14.26% | 17.14% | 12.02% |
Free Cash Flow Per Share | -0.06 | 0.32 | 0.91 | 2.66 | 3.09 | 1.94 |
Cash Interest Paid | 64.4 | 64.4 | 44.3 | 42.2 | 43.2 | 47.3 |
Cash Income Tax Paid | 22.7 | 22.7 | 23.6 | 35.9 | 49.5 | 29.8 |
Levered Free Cash Flow | 90.48 | 90.15 | 177.71 | 165.64 | 377.4 | -6.21 |
Unlevered Free Cash Flow | 135.47 | 128.7 | 203.65 | 189.79 | 401.87 | 11.04 |
Change in Working Capital | -30.38 | -31.01 | -81.57 | -39.42 | 18.16 | -41.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.